title: Bromocriptine: its place in type 2 diabetes Tx.
abstract: Patients intolerant of other diabetes medications or requiring minimal A1c reduction may benefit from bromocriptine.
authors: College of Pharmacy, Department of Pharmacotherapy and Translational Research, University of Florida, Gainesville, FL, USA. ksando@cop.ufl.edu
authors: Karen R
authors: KR
authors: Sando
authors: James
authors: J
authors: Taylor
mesh_terms: D001786:Blood Glucose / Q000187:drug effects; D001971:Bromocriptine / Q000494:pharmacology / Q000627:therapeutic use*; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D018491:Dopamine Agonists / Q000494:pharmacology / Q000627:therapeutic use*; D006442:Glycated Hemoglobin / Q000187:drug effects; D006801:Humans; D007004:Hypoglycemic Agents / Q000494:pharmacology / Q000627:therapeutic use*
chemical_list: D001786:Blood Glucose; D001971:Bromocriptine; D018491:Dopamine Agonists; D006442:Glycated Hemoglobin; D007004:Hypoglycemic Agents; C517652:hemoglobin A1c protein, human